Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Yu. Sh. Khalimov"'
Publikováno v:
Сахарный диабет, Vol 27, Iss 1, Pp 93-103 (2024)
Chronic kidney disease (CKD) is a common complication of diabetes mellitus. It increases significantly cardiovascular risk and decreases the quality of life. CKD requires treatment, and the treatment paradigm for type 2 diabetes has shifted from a gl
Externí odkaz:
https://doaj.org/article/411bbec21f634fb893ec0c81e626e8f1
Publikováno v:
Журнал инфектологии, Vol 14, Iss 2, Pp 27-38 (2022)
This review article discusses the pathophysiological mechanisms of the development of coronavirus infection in obese patients. It has been shown that obesity is considered as the most important risk factor for the development of many comorbid disease
Externí odkaz:
https://doaj.org/article/0afe8555e6e94200afba315b6094a587
Autor:
I. I. Dedov, N. G. Mokrysheva, G. A. Melnichenko, R. V. Rozhivanov, A. A. Kamalov, А. M. Mkrtumyan, Yu. Sh. Khalimov, N. V. Vorokhobina
Publikováno v:
Ожирение и метаболизм, Vol 18, Iss 4, Pp 496-507 (2022)
Hypogonadism in males, defined as a decrease in serum testosterone levels in combination with characteristic symptoms and/or signs, can be observed with pathological changes in the testicles and/or pituitary gland, such as Klinefelter’s syndrome, K
Externí odkaz:
https://doaj.org/article/b92a0a015bf64192b142addcfc0dfa7a
Autor:
Yu. M. Lopatin, G. P. Arutyunov, A. S. Ametov, F. T. Ageev, M. B. Antsiferov, O. L. Barbarash, S. V. Villevalde, N. G. Vinogradova, G. R. Galstyan, A. S. Galyavich, S. R. Gilyarevsky, M. G. Glezer, I. V. Zhirov, M. V. Ilyin, A. Yu. Lebedeva, S. V. Nedogoda, V. V. Salukhov, E. I. Tarlovskaya, S. N. Tereshchenko, I. V. Fomin, Yu. Sh. Khalimov, D. V. Cherkashin
Publikováno v:
Российский кардиологический журнал, Vol 27, Iss 3 (2022)
An online expert meeting held on November 17, 2021 reviewed the results of the randomized, double-blind, multinational, parallel-group EMPULSE trial, evaluating the clinical benefit and safety of the sodium-glucose co-transporter-2 inhibitor (SGLT2i)
Externí odkaz:
https://doaj.org/article/ee648580dd8b4bcaa3917713fdc86a35
Autor:
Yu. Sh. Khalimov, V. G. Kuzmich
Publikováno v:
Медицинский совет, Vol 0, Iss 21, Pp 189-197 (2020)
The article discusses the potential opportunities for impact of antidiabetic drugs from the group of glucagon-like peptide-1 (GLP- 1) receptor agonists on the risks of development and progression of cardiovascular complications in patients with type
Externí odkaz:
https://doaj.org/article/ccf9ea4b30fc4e22b135ce49f488213d
Autor:
G. P. Arutyunov, S. A. Boytsov, M. I. Voevoda, O. M. Drapkina, V. V. Kukharchuk, A. I. Martynov, M. V. Shestakova, V. S. Gurevich, I. V. Sergienko, A. S. Alieva, N. M. Akhmedzhanov, M. G. Bubnova, A. S. Galyavich, I. G. Gordeev, M. V. Yezhov, Yu. A. Karpov, V. O. Konstantinov, S. V. Nedogoda, E. M. Nifontov, Y. A. Orlova, A. V. Panov, S. A. Saiganov, V. V. Skibitsky, E. I. Tarlovskaya, S. A. Urazgildeeva, Yu. Sh. Khalimov
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 9, Pp 44-51 (2019)
In opinion the Expert council provides management tactics for patients with hypertriglyceridemia (HTG). It is demonstrated that HTG is a common condition in overweight patients and is an important component of residual risk. HTG creates additional co
Externí odkaz:
https://doaj.org/article/1eaf4fd217b84091ba3e9c5568297eeb
Autor:
G. P. Arutyunov, S. A. Boytsov, M. I. Voyevoda, V. S. Gurevich, O. M. Drapkina, V. V. Kukharchuk, A. I. Martynov, I. V. Sergiyenko, M. V. Shestakova, A. S. Aliyeva, N. M. Akhmedzhanov, M. G. Bubnova, А. S. Galyavich, I. G. Gordeyev, M. V. Ezhov, Yu. A. Karpov, V. O. Konstantinov, S. V. Nedogoda, E. M. Nifontov, Ya. A. Orlova, A. V. Panov, S. A. Sayganov, V. V. Skibitskiy, E. I. Tarlovskaya, S. A. Urazgildeyeva, Yu. Sh. Khalimov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 15, Iss 2, Pp 282-288 (2019)
Tactics for the management of patients with hypertriglyceridemia (HTG) is provided in the conclusion of the Advisory Board. It is demonstrated that HTG is quite prevalent in patients with excessive body weight and is an important component of residua
Externí odkaz:
https://doaj.org/article/59663c0f481145f497a617261716fda8
Autor:
G. P. Arutyunov, A. G. Arutyunov, E. I. Tarlovskaya, A. S. Ametov, N. G. Vinogradova, A. A. Garganeeva, M. G. Glezer, I. V. Zhirov, M. V. Ilyin, N. A. Koziolova, A. O. Konradi, A. Yu. Lebedeva, Yu. M. Lopatin, S. V. Nedogoda, V. V. Salukhov, M. Yu. Sitnikova, S. N. Tereshchenko, S. N. Tolstov, Yu. Sh. Khalimov, N. R. Khasanov, A. I. Chesnikova, V. Giga, M. Paсker
Publikováno v:
Российский кардиологический журнал, Vol 25, Iss 11 (2020)
At the online meeting held on September 3, 2020, the results of the international multicenter trial EMPEROR-REDUCED were considered. Number of proposals and recommendations for the further study of cardiovascular and renal effects of empagliflozin an
Externí odkaz:
https://doaj.org/article/a3a3f78f9f8848ac8a0840a2dddb6e4c
Autor:
A. V. Prokhorov, Yu. Sh. Khalimov, S. V. Gayduk, S. V. Gavrilin, D. P. Meshakov, A. I. Chepel
Publikováno v:
Вестник анестезиологии и реаниматологии, Vol 14, Iss 5, Pp 66-72 (2018)
Trauma injuries account for high mortality and disability in the cohort of the employable population. Pulmonary infectious complications in those injured with multiple traumas contribute the most to mortality of such patients. The article describes r
Externí odkaz:
https://doaj.org/article/226c55e53d7944beaf95df3ee5d3f25c
Autor:
A. V. Prokhorov, Yu. Sh. Khalimov, S. V. Gayduk, S. V. Gavrilin, D. P. Meshakov, A. I. Chepel
Publikováno v:
Вестник анестезиологии и реаниматологии, Vol 14, Iss 2, Pp 80-88 (2018)
Trauma is one leading cause of death in young patients under 45 years old and it occupies the third pace among causes of general mortality for the whole population. Nosocomial infections (first of all ventilator-associated pneumonia) account for mort
Externí odkaz:
https://doaj.org/article/1c357b924ed54b92b09d80a3872d16b7